Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.53 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.53 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.53 |
| ▸ | GJB2 | P29033 | 2/20 | 0.49 |
| ▸ | AMY2A | P04746 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.43 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | IGF2R | P11717 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18160494 | 1.00 | LGALS3 (0.53) | LGALS3LGALS8LGALS4GJB2AMY2A | |
| SCHEMBL21813015 | 0.92 | LGALS8 (0.57) | LGALS3LGALS8LGALS4GJB2AMY2A | |
| SCHEMBL20262949 | 0.90 | GJB2 (0.61) | LGALS3LGALS8LGALS4GJB2 | |
| SCHEMBL7779160 | 0.90 | GJB2 (0.61) | LGALS3LGALS8LGALS4GJB2 | |
| SCHEMBL411272 | 0.90 | GJB2 (0.61) | LGALS3LGALS8LGALS4GJB2 | |
| SCHEMBL411623 | 0.90 | GJB2 (0.61) | LGALS3LGALS8LGALS4GJB2 | |
| SCHEMBL10261434 | 0.87 | LGALS3 (0.67) | LGALS3LGALS8LGALS4GJB2MEN1 | |
| SCHEMBL6815726 | 0.87 | LGALS3 (0.67) | LGALS3LGALS8LGALS4GJB2MEN1 | |
| SCHEMBL10292030 | 0.87 | LGALS3 (0.67) | LGALS3LGALS8LGALS4GJB2MEN1 | |
| SCHEMBL17547757 | 0.87 | LGALS3 (0.67) | LGALS3LGALS8LGALS4GJB2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | LGALS3 347/4885LGALS8 437/4885LGALS4 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.